Outcomes after first-line immunochemotherapy for primary mediastinal B cell lymphoma patients: a LYSA study.

Camus V, Rossi C, Sesques P, Lequesne J, Tonnelet D, Haioun C, Durot E, Willaume A, Gauthier M, Moles-Moreau M-P, et al. Outcomes after first-line immunochemotherapy for primary mediastinal B cell lymphoma patients: a LYSA study. Blood Adv. 2021.